Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UMODL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4EBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HN1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPSM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00674 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CASC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SDK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPO5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STIM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on